172 related articles for article (PubMed ID: 11825541)
1. Primary biliary cirrhosis: new thoughts on pathophysiology and treatment.
Mason A; Nair S
Curr Gastroenterol Rep; 2002 Feb; 4(1):45-51. PubMed ID: 11825541
[TBL] [Abstract][Full Text] [Related]
2. Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis.
Mason AL; Farr GH; Xu L; Hubscher SG; Neuberger JM
Am J Gastroenterol; 2004 Dec; 99(12):2348-55. PubMed ID: 15571581
[TBL] [Abstract][Full Text] [Related]
3. Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.
Sharon D; Chen M; Zhang G; Girgis S; Sis B; Graham D; McDougall C; Wasilenko ST; Montano-Loza A; Mason AL
Liver Int; 2015 Apr; 35(4):1442-50. PubMed ID: 25302564
[TBL] [Abstract][Full Text] [Related]
4. Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.
Mason AL; Lindor KD; Bacon BR; Vincent C; Neuberger JM; Wasilenko ST
Aliment Pharmacol Ther; 2008 Oct; 28(7):886-94. PubMed ID: 18627363
[TBL] [Abstract][Full Text] [Related]
5. Combination antiretroviral studies for patients with primary biliary cirrhosis.
Lytvyak E; Montano-Loza AJ; Mason AL
World J Gastroenterol; 2016 Jan; 22(1):349-60. PubMed ID: 26755881
[TBL] [Abstract][Full Text] [Related]
6. Linking human beta retrovirus infection with primary biliary cirrhosis.
Mason AL; Zhang G
Gastroenterol Clin Biol; 2010; 34(6-7):359-66. PubMed ID: 20580176
[TBL] [Abstract][Full Text] [Related]
7. Proof of principal studies to assess the role of the human betaretrovirus in patients with primary biliary cirrhosis.
Mason A; Xu L; Neuberger J
Am J Gastroenterol; 2004 Dec; 99(12):2499-500. PubMed ID: 15571601
[No Abstract] [Full Text] [Related]
8. Does a betaretrovirus infection trigger primary biliary cirrhosis?
Xu L; Shen Z; Guo L; Fodera B; Keogh A; Joplin R; O'Donnell B; Aitken J; Carman W; Neuberger J; Mason A
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8454-9. PubMed ID: 12832623
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis.
Sasaki M; Kakuda Y; Miyakoshi M; Sato Y; Nakanuma Y
J Clin Pathol; 2014 Jun; 67(6):470-6. PubMed ID: 24407434
[TBL] [Abstract][Full Text] [Related]
10. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis.
Selmi C; Ross SR; Ansari AA; Invernizzi P; Podda M; Coppel RL; Gershwin ME
Gastroenterology; 2004 Aug; 127(2):493-501. PubMed ID: 15300582
[TBL] [Abstract][Full Text] [Related]
11. Viral induction of type 2 diabetes and autoimmune liver disease.
Mason A
J Nutr; 2001 Oct; 131(10):2805S-2808S. PubMed ID: 11584111
[TBL] [Abstract][Full Text] [Related]
12. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence.
Sasaki M; Ikeda H; Yamaguchi J; Nakada S; Nakanuma Y
Hepatology; 2008 Jul; 48(1):186-95. PubMed ID: 18536059
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.
Van de Water J; Gerson LB; Ferrell LD; Lake JR; Coppel RL; Batts KP; Wiesner RH; Gershwin ME
Hepatology; 1996 Nov; 24(5):1079-84. PubMed ID: 8903379
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
Sasaki M; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for the treatment of Primary Biliary Cholangitis.
Ali AH; Tabibian JH; Carey EJ; Lindor KD
Expert Opin Emerg Drugs; 2016; 21(1):39-56. PubMed ID: 26901615
[TBL] [Abstract][Full Text] [Related]
16. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of primary biliary cirrhosis.
Ali AH; Carey EJ; Lindor KD
Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
[TBL] [Abstract][Full Text] [Related]
18. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of autoantibodies in primary biliary cirrhosis.
Nakamura M
Semin Liver Dis; 2014 Aug; 34(3):334-40. PubMed ID: 25057956
[TBL] [Abstract][Full Text] [Related]
20. [Primary biliary cirrhosis (PBC): concept, pathogenesis and classification].
Aizawa Y; Toda G
Nihon Rinsho; 1994 Jan; 52(1):240-56. PubMed ID: 8114300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
